Results 71 to 80 of about 8,311 (216)

What Is Your Diagnosis? Lymph Node Aspirate From a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
William Benedict   +3 more
wiley   +1 more source

Waldenstrom\u27s macroglobulinemia terminating in acute myeloid leukemia [PDF]

open access: yes, 2006
Waldenstrom\u27s macroglobulinemia (WM) is a rare condition, accounting for approximately 2% of haematologic malignancies. The most common causes of death in these patients are progression of the malignant lymphoproliferative process, infection and ...
Adil, Salman   +2 more
core  

Penyakit Waldenstrom Makroglobulinemia [PDF]

open access: yes, 2016
Penyakit Waldenstrom Makroglobulinemia adalah kelainan limfoproliferatif sel B yang tidak umum, ditandai dengan infiltrasi sumsum tulang dan produksi immunoglobulin monoklonal IgM.
Wirawan, Riadi, Purnamasari, Endah
core   +1 more source

Bone Marrow Pathology in Cold Agglutinin‐Mediated Autoimmune Hemolytic Anemia: A Study of 56 Cases

open access: yesEuropean Journal of Haematology, Volume 117, Issue 2, Page 384-395, August 2026.
ABSTRACT Cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia (AIHA). CAD occurs in the context of a small clonal B‐cell lymphoproliferation restricted to blood and/or bone marrow (BM), without overt or extramedullary lymphoma. The WHO‐HAEM5 introduced a description of the CAD‐associated lymphoproliferative disorder (CAD‐LPD) in ...
Anne‐Marie L. Becking   +6 more
wiley   +1 more source

A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib

open access: yesCase Reports in Hematology, 2018
Bing–Neel syndrome is a rare manifestation of Waldenström macroglobulinemia characterized by lymphoplasmacytic cells’ infiltration into the central nervous system.
Daniel S. O’Neil   +5 more
doaj   +1 more source

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

open access: yesInternational Journal of Cancer, Volume 159, Issue 2, Page 410-422, 15 July 2026.
What's new? Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic precursor to multiple myeloma, sharing substantial genetic features with overt malignancy. Given evidence implicating autophagy in myeloma risk, this study examined whether genetic variations in autophagy‐related genes influence MGUS susceptibility.
José Manuel Sánchez‐Maldonado   +54 more
wiley   +1 more source

Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria

open access: yes, 2023
Consensus Panel 4 (CP4) of the 11th International Workshop on Waldenstrom's Macroglobulinemia (IWWM-11) was tasked with reviewing the current criteria for diagnosis and response assessment.
Benevolo, G.   +15 more
core  

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease

open access: yes, 2011
The combination of fludarabine, cyclophosphamide, and rituximab (FCR) has produced promising results in chronic lymphocytic leukemia and other lymphoproliferative disorders.
Carlo Visco   +29 more
core   +1 more source

Bing–Neel syndrome, a rare manifestation of WM; a case report and review of literature

open access: yesClinical Case Reports
Key Clinical Message Bing–Neel syndrome (BNS) is a rare manifestation in individuals suffering from Waldenström macroglobulinemia (WM). Neurological signs and symptoms in this syndrome are almost difficult to be differentiated from other common ...
Hamid Rezvani   +4 more
doaj   +1 more source

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

open access: yesNature Communications, 2018
Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is a non-Hodgkin-type B cell lymphoma. Here, the authors identify two risk loci for WM/LPL in a two-stage GWAS involving a family-oversampling approach and provide evidence for a ...
Mary L. McMaster   +80 more
doaj   +1 more source

Home - About - Disclaimer - Privacy